Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinoma.

Fox, Elizabeth

Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinoma. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Aug 2013 - 4239-48 p. digital

Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural

1557-3265

10.1158/1078-0432.CCR-13-0071 doi


Adolescent
Carcinoma, Medullary--drug therapy
Carcinoma, Neuroendocrine
Child
Child, Preschool
Drug-Related Side Effects and Adverse Reactions--pathology
Gene Expression Regulation, Neoplastic
Germ-Line Mutation
Humans
Multiple Endocrine Neoplasia Type 2b--drug therapy
Neoplasm Metastasis
Neoplasm Recurrence, Local--drug therapy
Piperidines--administration & dosage
Protein-Tyrosine Kinases--genetics
Proto-Oncogene Mas
Proto-Oncogene Proteins c-ret--genetics
Quinazolines--administration & dosage
Thyroid Neoplasms--drug therapy